Eballena, Bb Girl .
HRN: 27-91-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2025
AMPICILLIN 250MG (VIAL)
10/06/2025
10/13/2025
IV DRIP
125mg
Q12h
PSNB( Thickly MSAF)
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes